Events and Presentations
B & T Cell-Mediated Autoimmune Disease Drug Development Summit
- Presentation: Evelyn Peelen, Ph.D., Senior Manager Translational Pharmacology at Immunic
- Title: IMU-935, a potent RORyt inverse agonist, effectively inhibits T helper 17 cells but maintains normal thymocyte development
- Date/Time: Thursday, July 28, 2022, 11:00 am EDT